Recall: D-1413-2020

Class II - Potentially Harmful

Class IIClassification

2020-07-17Initiated

TerminatedStatus

Lupin Pharmaceuticals Inc.Firm

Product

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

Reason

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Distribution

Product was distributed to OH and may have been further distributed throughout the United States.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.